Figainin 1, a Novel Amphibian Skin Peptide with Antimicrobial and Antiproliferative Properties

Amphibian skin secretions are abundant in bioactive compounds, especially antimicrobial peptides. These molecules are generally cationic and rich in hydrophobic amino acids, have an amphipathic structure and adopt an α-helical conformation when in contact with microorganisms membranes. In this work,...

Full description

Bibliographic Details
Main Authors: Carlos José Correia Santana, Ana Carolina Martins Magalhães, Agenor C. M. dos Santos Júnior, Carlos André Ornelas Ricart, Beatriz D. Lima, Alice da Cunha Morales Álvares, Sonia Maria de Freitas, Osmindo Rodrigues Pires, Wagner Fontes, Mariana S. Castro
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/9/9/625
Description
Summary:Amphibian skin secretions are abundant in bioactive compounds, especially antimicrobial peptides. These molecules are generally cationic and rich in hydrophobic amino acids, have an amphipathic structure and adopt an α-helical conformation when in contact with microorganisms membranes. In this work, we purified and characterized Figainin 1, a novel antimicrobial and antiproliferative peptide from the cutaneous secretion of the frog <i>Boana raniceps</i>. Figainin 1 is a cationic peptide with eighteen amino acid residues—rich in leucine and isoleucine, with an amidated C-terminus—and adopts an α-helical conformation in the presence of trifluoroethanol (TFE). It displayed activity against Gram-negative and especially Gram-positive bacteria, with MIC values ranging from 2 to 16 µM, and showed an IC<sub>50</sub> value of 15.9 µM against epimastigote forms of <i>T. cruzi</i>; however, Figanin 1 did not show activity against <i>Candida</i> species. This peptide also showed cytolytic effects against human erythrocytes with an HC<sub>50</sub> of 10 µM, in addition to antiproliferative activity against cancer cells and murine fibroblasts, with IC<sub>50</sub> values ranging from 10.5 to 13.7 µM. Despite its adverse effects on noncancerous cells, Figainin 1 exhibits interesting properties for the development of new anticancer agents and anti-infective drugs against pathogenic microorganisms.
ISSN:2079-6382